JAN 16, 2020 1:00 PM PST

Babies in Africa Receive World's First Malaria Vaccine

WRITTEN BY: Tiffany Dazet

Would you accept a vaccine that was only 40% effective? For those at risk of malaria, the answer is likely a resounding, "yes!" According to the World Health Organization (WHO), malaria kills more than 400,000 people each year, two-thirds of which are under the age of five. The WHO estimates that one child dies from malaria every two minutes.

The world's first malaria vaccine program was rolled out last year in Malawi, Kenya, and Ghana. Currently, the vaccine is only available to babies in these select regions. However, the ultimate goal is to disperse it throughout Africa.

Although the efficacy of the vaccine is estimated at 40%, the AP reports that experts consider it worthy of an attempt as resistance to treatment is growing. According to the WHO, this first-generation vaccine known as RTS,S/AS01 (RTS,S) acts against Plasmodium falciparum, which is the most deadly malaria parasite worldwide and most prevalent in Africa. Clinical testing occurred in seven African countries and showed promise to prevent malaria. The WHO reports that children who receive four doses of RTS,S suffer "significantly fewer cases of malaria, including severe, life-threatening malaria," when compared to those who did not receive the vaccine.

According to the WHO, the goal of the Malaria Vaccine Implementation Programme (MVIP) is to reach 360,000 children per year in the selected countries. The first vaccine dose is given at about five months of age, then doses two and three at monthly intervals, and the fourth final dose when the child is about two years of age. With this rollout program, stakeholders hope to determine the feasibility of delivering the required four doses, the vaccine's role in reducing deaths, and the vaccine's safety profile.

The AP reports that the development of this vaccine took about 30 years of research, citing the parasite's complex life cycle as a significant hurdle. Ashley Birkett, director of PATH's Malaria Vaccine Initiative, told AP reporters, "We don't have any vaccines against parasites in routine use. This is uncharted territory."

The WHO states that the MVIP is expected to continue through 2022. Additionally, the WHO says that this vaccine was developed specifically for Africa and African children, who "bear the greatest burden of malaria worldwide." Future studies are needed before RTS,S can be considered for use outside of Africa.

Sources: AP News, World Health Organization 

About the Author
  • Tiffany grew up in Southern California, where she attended San Diego State University. She graduated with a degree in Biology with a marine emphasis, thanks to her love of the ocean and wildlife. With 13 years of science writing under her belt, she now works as a freelance writer in the Pacific Northwest.
You May Also Like
MAR 23, 2021
Clinical & Molecular DX
AI Test Distinguishes Cancer Cells From Healthy Ones Based on Acidity Levels
MAR 23, 2021
AI Test Distinguishes Cancer Cells From Healthy Ones Based on Acidity Levels
Researchers have developed a new way of differentiating cancer cells from healthy ones—by how acidic they are. The ...
APR 13, 2021
Clinical & Molecular DX
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
APR 13, 2021
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
German researchers have developed an innovative method for continuously tracking and monitoring biomarkers and drugs cir ...
APR 18, 2021
Cell & Molecular Biology
Controlling the Epigenome with CRISPRoff & CRISPRon
APR 18, 2021
Controlling the Epigenome with CRISPRoff & CRISPRon
Some parts of the genome are simple; many genes encode for proteins, and if there is an error in one of those protein-co ...
APR 19, 2021
Cell & Molecular Biology
Insight Into the Molecular Basis of Rheumatoid Arthritis
APR 19, 2021
Insight Into the Molecular Basis of Rheumatoid Arthritis
New research has shown how variants in an immune gene can lead to a high risk of developing the autoimmune disorder rheu ...
APR 20, 2021
Cardiology
How Low Can You Go? Diastolic Blood Pressure Standards May Change
APR 20, 2021
How Low Can You Go? Diastolic Blood Pressure Standards May Change
Blood pressure readings are a standard part of even the most basic health checks. Now some researchers are suggesting th ...
APR 20, 2021
Health & Medicine
Cannabis Users Tend to Exercise More
APR 20, 2021
Cannabis Users Tend to Exercise More
Two recent studies have shown that far from performing less exercise, people who use marijuana are actually more active. ...
Loading Comments...